Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood); physician interpretation and report, when required

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86153 refers to a specialized laboratory test that involves the enumeration of cells using immunologic selection and identification techniques in a fluid specimen, such as blood. This procedure is particularly significant in the context of oncology, as it is utilized to detect circulating tumor cells (CTCs) in patients who have been diagnosed with cancer. The identification of these cells is crucial because it provides insights into the metastatic spread of cancer, which occurs when tumor cells disseminate from the primary site and deposit in other organs through the circulatory system, including blood, bone marrow, and lymphatic pathways. The presence of circulating tumor cells in body fluids can serve as an important biomarker for assessing disease prognosis and guiding treatment decisions for various types of cancers, including but not limited to breast, colorectal, prostate, renal, bladder, and non-small cell lung cancers. Typically, a higher count of circulating tumor cells correlates with a poorer survival rate, making this test a valuable tool in the management of cancer patients. The procedure requires the collection of a fluid sample, which may be obtained through methods such as venipuncture for blood, bone marrow biopsy for bone marrow samples, or other techniques for lymphatic fluid. The testing may involve a cell search method that yields a positive result if five or more tumor cells are detected, or it may utilize morphological appearance, which necessitates microscopic examination to visualize and identify the cells. In some cases, a physician's interpretation and report of the findings may be required to provide a comprehensive understanding of the results and their implications for patient care.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 86153 is indicated for the following conditions:

  • Detection of Circulating Tumor Cells This test is performed to identify the presence of circulating tumor cells in patients diagnosed with various types of cancer, which can provide critical information regarding the metastatic spread of the disease.
  • Prognostic Assessment The enumeration of circulating tumor cells can help determine the prognosis of the disease, as the presence of these cells often correlates with a lower survival rate.
  • Treatment Monitoring The test may be utilized to monitor the effectiveness of ongoing treatment regimens in cancer patients, allowing for adjustments based on the presence or absence of circulating tumor cells.
  • Specific Cancer Types This procedure is particularly relevant for cancers such as breast, colorectal, prostate, renal, bladder, and non-small cell lung cancer, where the detection of circulating tumor cells can influence treatment decisions.

2. Procedure

The procedure for CPT® Code 86153 involves several key steps that ensure accurate enumeration and identification of circulating tumor cells in a fluid specimen.

  • Sample Collection A fluid specimen, typically blood, is obtained from the patient. This is usually performed through a separately reportable venipuncture, where a needle is inserted into a vein to draw blood. In cases where bone marrow or lymphatic fluid is required, appropriate methods such as bone marrow biopsy or other techniques are employed to collect the necessary samples.
  • Cell Enumeration Once the fluid specimen is collected, it undergoes a cell enumeration process. This may involve the use of a cell search method, which identifies circulating tumor cells based on specific immunologic markers. A positive result is indicated if five or more tumor cells are detected in the sample. Alternatively, morphological appearance techniques may be used, which require microscopic examination to visualize and identify the tumor cells based on their characteristics.
  • Physician Interpretation After the enumeration process, a physician may be required to interpret the results. This interpretation is crucial for understanding the clinical significance of the findings, particularly in relation to the patient's cancer diagnosis and treatment plan. The physician's report will summarize the results and provide insights into the implications for the patient's care.

3. Post-Procedure

Post-procedure care for patients undergoing the test associated with CPT® Code 86153 typically involves monitoring for any immediate complications related to the sample collection, such as bruising or discomfort at the venipuncture site. Patients may be advised to follow up with their healthcare provider to discuss the results of the test and any necessary changes to their treatment plan based on the findings. The physician's interpretation and report will guide further management decisions, including potential additional testing or adjustments to therapy, depending on the presence and quantity of circulating tumor cells detected.

Short Descr CELL ENUMERATION PHYS INTERP
Medium Descr CELL ENUMERATION IMMUNE SELECTJ & ID PHYS INTERP
Long Descr Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood); physician interpretation and report, when required
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 6 - Laboratory Physician Interpretation Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions Mod 26: 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x)
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
GZ Item or service expected to be denied as not reasonable and necessary
Date
Action
Notes
2013-01-01 Added Added
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"